Hemal Shah

Value Matters, LLC

Hemal Shah, PharmD is Principal/Owner of Value Matters, LLC and has over 20 years of experience in health economics & outcomes research, real world evidence generation, pricing, market access, value demonstration and health policy.  She currently HEOR & market access strategic consulting services for clients in the life science industry.  Hemal has worked with leading pharmaceutical and biotechnology companies, health care delivery organizations, and industry groups. Prior to establishing her consulting business in 2014, Hemal was Senior Vice President, Medical Affairs, Healthcare Quality, Policy and Outcomes at Optimer Pharmaceuticals (acquired by Cubist pharmaceuticals) from January 2011 to December 2013 where she was responsible for overall leadership, strategy, vision and execution of the Medical Affairs, Health Economics & Outcomes Research, Healthcare Quality/Public Policy and New Products/Life Cycle Planning teams and managed the establishment/expansion of field-based MSL and  HEOR teams.

Hemal’s work has covered a wide variety of therapeutic areas including: respiratory, cardiovascular/stroke, metabolic, male and female health, infectious diseases, pain, oncology, and rare diseases. She has also worked with cross functional teams to develop long-term plans in areas including Medical Affairs, Managed Markets, HEOR, Pipeline Products, and Real World Evidence.

Hemal holds a Doctor of Pharmacy from The State University of New Jersey, a BSc. in Pharmacy and a BSc. in Molecular & Cell Biology from University of Connecticut and has completed a post-doctoral fellowship in outcomes research at Geisinger Health System/Novartis.



Stay Connected with MAPS

Join MAPS on LinkedIn to further build your professional connections within Medical Affairs through our Company and Group Pages.

Follow us on Twitter and say abreast of MAPS activities and key issues for Medical Affairs professionals.